Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-112179

Chief Executive Officer sold 2,782 shares at $5.20 ($14,452)

From the SEC's structured data for this filing

Trades in this filing

Rawcliffe Adrian · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-09-01 Sale : show line 1 in the form −2,782 $5.20 $14,452 3,070 D
Open-market sales · 2,782 sh · avg $5.20 · $14,452
Loading xslF345X03/tm2126797-1_4seq1.xml…